Author

Moutushy Mitra

Observed name: Moutushy Mitra Kandalam

Institutions: Sankara Nethralaya, Vision Research Foundation

Observed institutions: Sankara Nethralaya, Vision Research Foundation, SASTRA University

ORCID: 0000-0003-1306-2959

Observed ORCID: 0000-0003-1306-2959

OpenAlex ID: A5083511568

Retraction notice to ``Enhanced Antiproliferative Activity of Carboplatin loaded Chitosan-Alginate Nanoparticles in Retinoblastoma Cell Line’’ [Acta Biomaterialia 6 (2010) 3120–3131]

2010 · Suphiya Parveen, Moutushy Mitra, et al. · Acta Biomaterialia · 63

A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs.

2012 · Moutushy Mitra, Chandana Mohanty, et al. · PubMed Central · 51

Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.

2013 · Moutushy Mitra, Mallikarjuna Kandalam, et al. · PubMed Central · 49

Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma.

2012 · Moutushy Mitra Kandalam, Madhu Beta, et al. · PubMed Central · 38

EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.

2012 · Moutushy Mitra, Mallikarjuna Kandalam, et al. · PubMed Central · 37

KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association.

2009 · Jagadeesan Madhavan, Moutushy Mitra, et al. · PubMed · 34

Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.

2011 · Moutushy Mitra, Ranjita Misra, et al. · Europe PMC (PubMed Central) · 26

Genome-wide changes accompanying the knockdown of Ep-CAM in retinoblastoma.

2010 · Moutushy Mitra, Mallikarjuna Kandalam, et al. · PubMed Central · 26

Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy

2010 · Moutushy Mitra, Fahima Dilnawaz, et al. · Cancer Nanotechnology · 24

Reversal of Stathmin-Mediated Microtubule Destabilization Sensitizes Retinoblastoma Cells to A Low Dose of Antimicrotubule Agents: A Novel Synergistic Therapeutic Intervention

2011 · Moutushy Mitra, Mallikarjuna Kandalam, et al. · Investigative Ophthalmology & Visual Science · 22

Molecular pathology of retinoblastoma

2010 · Jyotirmay Biswas, Mallikarjuna Kandalam, et al. · Middle East African Journal of Ophthalmology · 10

Retraction notice to “Enhanced antiproliferative activity of carboplatin loaded chitosan-alginate nanoparticles in retinoblastoma cell line” [Acta Biomaterialia 6 (2010) 3120–3131]

2013 · Suphiya Parveen, Moutushy Mitra, et al. · Acta Biomaterialia · 2

Erratum to: Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy

2011 · Moutushy Mitra, Fahima Dilnawaz, et al. · Cancer Nanotechnology

Works count: 15

Citation count: 382

H-index: 10

I10-index: 11